Antimicrobial agents and chemotherapy

• 

  Año 2005, Vol. 49, Número 8

  • Inactivation of the FCY2 Gene Encoding Purine-Cytosine Permease Promotes Cross-Resistance to Flucytosine and Fluconazole in Candida lusitaniae

    F. Chapeland Leclerc

    págs. 3101-3108

    

  • 3',5'-Cyclic Diguanylic Acid Reduces the Virulence of Biofilm-Forming Staphylococcus aureus Strains in a Mouse Model of Mastitis Infection

    E. Brouillette

    págs. 3109-3113

    

  • Functional Interrelationships between Cell Membrane and Cell Wall in Antimicrobial Peptide-Mediated Killing of Staphylococcus aureus

    Y. Q. Xiong, K. Mukhopadhyay

    págs. 3114-3121

    

  • Neopeptide Antibiotics That Function as Opsonins and Membrane-Permeabilizing Agents for Gram-Negative Bacteria

    H. Tsubery, H. Yaakov

    págs. 3122-3128

    

  • Role of the AcrAB-TolC Efflux Pump in Determining Susceptibility of Haemophilus influenzae to the Novel Peptide Deformylase Inhibitor LBM415

    D. M. Daigle, S. Narayan, C. R. Dean, J. L. Dzink-Fox

    págs. 3129-3135

    

  • Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis

    E. S. Soteriades, A. Michalopoulos, S. K. Kasiakou

    págs. 3136-3146

    

  • Countrywide Survey Shows Very High Prevalence of Plasmodium falciparum Multilocus Resistance Genotypes in Cambodia

    N. Khim, M.-T. Ekala, C. Bouchier, S. Incardona

    págs. 3147-3152

    

  • Mechanism of Inhibition of Vaccinia Virus DNA Polymerase by Cidofovir Diphosphate

    K. Y. Hostetler, W. C. Magee

    págs. 3153-3162

    

  • Efficacy of Telavancin in a Rabbit Model of Aortic Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus or Vancomycin-Intermediate Staphylococcus aureus

    A. G. Madrigal

    págs. 3163-3165

    

  • Real-Time PCR Screening for 16S rRNA Mutations Associated with Resistance to Tetracycline in Helicobacter pylori

    E. Glocker, M. Berning, M. M. Gerrits, J. G. Kusters

    págs. 3166-3170

    

  • Fluconazole MIC and the Fluconazole Dose/MIC Ratio Correlate with Therapeutic Response among Patients with Candidemia

    C. J. Clancy

    págs. 3171-3177

    

  • Pharmacodynamic Evidence that Ciprofloxacin Failure against Tuberculosis Is Not Due to Poor Microbial Kill but to Rapid Emergence of Resistance

    T. Gumbo, A. Louie, G. L. Drusano, M. R. Deziel

    págs. 3178-3181

    

  • Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans

    B. Carbonnelle, S. Etuaful

    págs. 3182-3186

    

  • In Vitro and In Vivo Evaluations of the Activities of Lauric Acid Monoester Formulations against Staphylococcus aureus

    M. S. Rouse

    págs. 3187-3191

    

  • Molecular Analysis of Cross-Resistance to Capreomycin, Kanamycin, Amikacin, and Viomycin in Mycobacterium tuberculosis

    C. E. Maus, B. B. Plikaytis

    págs. 3192-3197

    

  • Contribution of Acquired Carbapenem-Hydrolyzing Oxacillinases to Carbapenem Resistance in Acinetobacter baumannii

    C. Heritier

    págs. 3198-3202

    

  • Peptide Nucleic Acid Antisense Oligomer as a Therapeutic Strategy against Bacterial Infection: Proof of Principle Using Mouse Intraperitoneal Infection

    X.X. Tan, J. K. Actor

    págs. 3203-3207

    

  • Activity of the De Novo Engineered Antimicrobial Peptide WLBU2 against Pseudomonas aeruginosa in Human Serum and Whole Blood: Implications for Systemic Applications

    B. Deslouches

    págs. 3208-3216

    

  • Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections

    M. J. DiNubile

    págs. 3217-3221

    

  • Ciprofloxacin Induction of a Susceptibility Determinant in Pseudomonas aeruginosa

    R. E. W. Hancock, M. D. Brazas

    págs. 3222-3227

    

  • Effect of Ciprofloxacin-Induced Prostaglandin E~2 on Interleukin-18-Treated Monocytes

    H. K. Takahashi

    págs. 3228-3233

    

  • Lipophilic Antifolate Trimetrexate Is a Potent Inhibitor of Trypanosoma cruzi: Prospect for Chemotherapy of Chagas' Disease

    O. Senkovich

    págs. 3234-3238

    

  • In Vitro and In Vivo Antibacterial Activities of CS-023 (RO4908463), a Novel Parenteral Carbapenem

    T. Takenouchi, T. Koga, T. Abe, H. Inoue

    págs. 3239-3250

    

  • Mitochondrial Ribosome as the Target for the Macrolide Antibiotic Clarithromycin in the Helminth Echinococcus multilocularis

    A. Mathis

    págs. 3251-3255

    

  • Comparison of Four Methods for Determining Lysostaphin Susceptibility of Various Strains of Staphylococcus aureus

    C. M. Kusuma, J. F. Kokai Kun

    págs. 3256-3263

    

  • Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates

    R. Kelly, J. N. Kahn, S. Park

    págs. 3264-3273

    

  • Production and Characterization of Stable Amphotericin-Resistant Amastigotes and Promastigotes of Leishmania mexicana

    H. I. Al-Mohammed

    págs. 3274-3280

    

  • Secretion of Proteases by Pseudomonas aeruginosa Biofilms Exposed to Ciprofloxacin

    E. Oldak, E. A. Trafny

    págs. 3281-3288

    

  • Tn5393d, a Complex Tn5393 Derivative Carrying the PER-1 Extended-Spectrum beta-Lactamase Gene and Other Resistance Determinants

    G. M. Rossolini, E. Mantengoli

    págs. 3289-3296

    

  • Correspondence of In Vitro and In Vivo Fluconazole Dose-Response Curves for Cryptococcus neoformans

    R. A. Larsen

    págs. 3297-3301